The growth of Viagra and its influence on the drug landscape presents a intricate question for shareholders. While the early sales data were impressive, the exclusivity has lapsed, leading to a flood of off-brand https://zaynyqad620258.ssnblog.com/40011446/the-blue-pill-and-pharma-a-risky-investment